Ethnic differences in stroke outcomes in Aotearoa New Zealand: A national linkage study.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
07 2023
Historique:
medline: 29 6 2023
pubmed: 7 3 2023
entrez: 6 3 2023
Statut: ppublish

Résumé

Ethnic differences in post-stroke outcomes have been largely attributed to biological and socioeconomic characteristics resulting in differential risk factor profiles and stroke subtypes, but evidence is mixed. This study assessed ethnic differences in stroke outcome and service access in New Zealand (NZ) and explored underlying causes in addition to traditional risk factors. This national cohort study used routinely collected health and social data to compare post-stroke outcomes between NZ Europeans, Māori, Pacific Peoples, and Asians, adjusting for differences in baseline characteristics, socioeconomic deprivation, and stroke characteristics. First and principal stroke public hospital admissions during November 2017 to October 2018 were included (N = 6879). Post-stroke unfavorable outcome was defined as being dead, changing residence, or becoming unemployed. In total, 5394 NZ Europeans, 762 Māori, 369 Pacific Peoples, and 354 Asians experienced a stroke during the study period. Median age was 65 years for Māori and Pacific Peoples, and 71 and 79 years for Asians and NZ Europeans, respectively. Compared with NZ Europeans, Māori were more likely to have an unfavorable outcome at all three time-points (odds ratio (OR) = 1.6 (95% confidence interval (CI) = 1.3-1.9); 1.4 (1.2-1.7); 1.4 (1.2-1.7), respectively). Māori had increased odds of death at all time-points (1.7 (1.3-2.1); 1.5 (1.2-1.9); 1.7 (1.3-2.1)), change in residence at 3 and 6 months (1.6 (1.3-2.1); 1.3 (1.1-1.7)), and unemployment at 6 and 12 months (1.5 (1.1-2.1); 1.5 (1.1-2.1)). There was evidence of differences in post-stroke secondary prevention medication by ethnicity. We found ethnic disparities in care and outcomes following stroke which were independent of traditional risk factors, suggesting they may be attributable to stroke service delivery rather than patient factors.

Sections du résumé

BACKGROUND
Ethnic differences in post-stroke outcomes have been largely attributed to biological and socioeconomic characteristics resulting in differential risk factor profiles and stroke subtypes, but evidence is mixed.
AIMS
This study assessed ethnic differences in stroke outcome and service access in New Zealand (NZ) and explored underlying causes in addition to traditional risk factors.
METHODS
This national cohort study used routinely collected health and social data to compare post-stroke outcomes between NZ Europeans, Māori, Pacific Peoples, and Asians, adjusting for differences in baseline characteristics, socioeconomic deprivation, and stroke characteristics. First and principal stroke public hospital admissions during November 2017 to October 2018 were included (N = 6879). Post-stroke unfavorable outcome was defined as being dead, changing residence, or becoming unemployed.
RESULTS
In total, 5394 NZ Europeans, 762 Māori, 369 Pacific Peoples, and 354 Asians experienced a stroke during the study period. Median age was 65 years for Māori and Pacific Peoples, and 71 and 79 years for Asians and NZ Europeans, respectively. Compared with NZ Europeans, Māori were more likely to have an unfavorable outcome at all three time-points (odds ratio (OR) = 1.6 (95% confidence interval (CI) = 1.3-1.9); 1.4 (1.2-1.7); 1.4 (1.2-1.7), respectively). Māori had increased odds of death at all time-points (1.7 (1.3-2.1); 1.5 (1.2-1.9); 1.7 (1.3-2.1)), change in residence at 3 and 6 months (1.6 (1.3-2.1); 1.3 (1.1-1.7)), and unemployment at 6 and 12 months (1.5 (1.1-2.1); 1.5 (1.1-2.1)). There was evidence of differences in post-stroke secondary prevention medication by ethnicity.
CONCLUSION
We found ethnic disparities in care and outcomes following stroke which were independent of traditional risk factors, suggesting they may be attributable to stroke service delivery rather than patient factors.

Identifiants

pubmed: 36872640
doi: 10.1177/17474930231164024
pmc: PMC10311930
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-671

Références

Am J Public Health. 2014 Jun;104 Suppl 3:S368-76
pubmed: 24754653
Neurology. 2022 May 27;:
pubmed: 35623890
Prev Chronic Dis. 2019 Feb 14;16:E21
pubmed: 30767859
Stroke. 2003 Apr;34(4):999-1004
pubmed: 12649513
BMC Neurol. 2011 Jun 30;11:81
pubmed: 21714938
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1458-1465
pubmed: 29433932
Stroke. 2003 Apr;34(4):1027-31
pubmed: 12624220
Intern Med J. 2018 Mar;48(3):301-309
pubmed: 29034985
PM R. 2012 Apr;4(4):290-5
pubmed: 22541375
JMIR Res Protoc. 2021 Jan 12;10(1):e25374
pubmed: 33433396
Stroke Res Treat. 2014;2014:950746
pubmed: 25028619
Stroke. 2016 Sep;47(9):2183-8
pubmed: 27470991
Lancet. 2006 Jun 17;367(9527):2005-9
pubmed: 16782491
Intern Med J. 2019 Aug;49(8):962-968
pubmed: 30907045
Stroke. 2020 Nov;51(11):3425-3432
pubmed: 33104466
PLoS One. 2015 Aug 20;10(8):e0134609
pubmed: 26291829
Int J Stroke. 2019 Oct;14(7):686-695
pubmed: 30868940
Stroke. 2013 Feb;44(2):469-76
pubmed: 23306327
BMC Med. 2019 Oct 24;17(1):191
pubmed: 31647003
J Prim Health Care. 2020 Dec;12(4):318-326
pubmed: 33349319
Lancet Reg Health West Pac. 2022 Jan 03;20:100358
pubmed: 35036976
J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):888-93
pubmed: 19276102
Am J Public Health. 2006 Apr;96(4):612-7
pubmed: 16507721
Circulation. 2010 Apr 6;121(13):1492-501
pubmed: 20308617
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
Stroke. 2013 Aug;44(8):2174-81
pubmed: 23813988
Int J Epidemiol. 2019 Jun 1;48(3):1027
pubmed: 30879058
Ann Rehabil Med. 2016 Aug;40(4):675-81
pubmed: 27606274

Auteurs

Hayley J Denison (HJ)

Research Centre for Hauora and Health, Massey University, Wellington, New Zealand.

Marine Corbin (M)

Research Centre for Hauora and Health, Massey University, Wellington, New Zealand.

Jeroen Douwes (J)

Research Centre for Hauora and Health, Massey University, Wellington, New Zealand.

Stephanie G Thompson (SG)

Department of Medicine, University of Otago Wellington, Wellington, New Zealand.

Matire Harwood (M)

Department of Medicine, University of Auckland, Auckland, New Zealand.

Alan Davis (A)

Whangarei Hospital, Whangarei, New Zealand.

John N Fink (JN)

Christchurch Hospital, Christchurch, New Zealand.

P Alan Barber (PA)

Department of Medicine, University of Auckland, Auckland, New Zealand.

John H Gommans (JH)

Hawke's Bay Hospital, Hastings, New Zealand.

Dominique A Cadilhac (DA)

Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.

William Levack (W)

Department of Medicine, University of Otago Wellington, Wellington, New Zealand.

Harry McNaughton (H)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Joosup Kim (J)

Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.

Valery L Feigin (VL)

Auckland University of Technology, Auckland, New Zealand.

Virginia Abernethy (V)

Stroke Foundation New Zealand, Wellington, New Zealand.

Jackie Girvan (J)

Independent Consumer, Ashburton, New Zealand.

Andrew Wilson (A)

Wairau Hospital, Blenheim, New Zealand.

Anna Ranta (A)

Department of Medicine, University of Otago Wellington, Wellington, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH